An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies

Prevalence of clinically relevant functional limitations and symptoms

To describe the prevalence of clinically relevant functional limitations (e.g., physical and social) and symptoms (e.g., fatigue, pain and dyspnea) by type of hematologic malignancy and by type of treatment (e.g., standard chemotherapy of oral anticancer therapies)

Time frame: After 2 years from date of registration

Factors associated with physical and mental health concerns, as measured by EORTC QLQ-C30 questionnaire

To investigate factors associated with physical and mental health concerns

Time frame: After 2 years from date of registration

Financial and social impact imposed by the COVID-19 pandemic on patient health outcomes

To examine the financial and social impact imposed by the COVID-19 pandemic on patient health outcomes

Time frame: After 2 years from date of registration

Limitations in accessing routine medical care services imposed by the COVID-19 pandemic on patient health outcomes

To examine the limitations in accessing routine medical care services imposed by the COVID-19 pandemic on patient health outcomes

Time frame: After 2 years from date of registration

Clinical strategies adopted by physicians

To describe clinical strategies adopted by physicians in response to patient-generated alerts, across different clinical scenarios

Time frame: After 2 years from date of registration